RFXAP and pancreatic neoplasm: In a recent study, Ding et al. demonstrated that pancreatic cancer-derived EVs carry moR-212-3p, which inhibits the regulatory factor X-associated proteins (RFXAP), an important transcription factor that can lead to immune tolerance [66].